Series A · Biotech · Amsterdam, Netherlands · Founded 2018 · 51–200 employees
Scenic Biotech is an Amsterdam-based clinical-stage biotechnology company pioneering “modifier therapy,” a novel approach to discovering and developing transformative therapeutics that act on genetic modifier genes to rebalance disease pathways and address unmet medical needs in neurodegenerative, metabolic and rare diseases; the company uses its proprietary Cell-Seq platform to identify novel drug targets and has collaborations with major global pharma partners.
No open roles listed right now.